CLINICAL_TRIALS
trial_result
· 2024-05-31
Clinical Trial Update: Cannabidiol for ASD Open Trial [Phase 2]
Summary
Phase 2 open trial evaluating cannabidiol for autism spectrum disorder has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: ASD, Autism Spectrum Disorder | Phase 2 | Status: COMPLETED | Results posted: 2024-05-31